10.1161/HYPERTENSIONAHA.110.156554 115 MassiminoE.IzzoA.RiccardiG.PepaG
Gut microbiota composition and relapse risk in pediatric MS: a pilot study
The inhibition of inflammatory pathways reduces OS and improve neuropathic symptoms in experimental models (Negi et al., 2011a)
In experimental biological matrices, this degradation limits the effective exposure window and complicates dose-response characterization
Methods In this phase 3a, double-blind, randomized, placebo-controlled trial conducted in 12 countries, we assigned adults with a body-mass index of 27 or more, a glycated hemoglobin level of 7 to 10%, and type 2 diabetes in a 3:1 ratio to receive once-weekly cagrilintide-semaglutide (2.4 mg each) or placebo, along with lifestyle intervention, for 68 weeks